ClinicalTrials.Veeva

Menu
I

ITB Research | Miami, FL

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

ABP-671
Risankizumab
Iron

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 8 total trials

Extension Study of ABP-671 in Participants With Gout

The primary objectives of this study are to assess the safety, tolerability, and efficacy of ABP-671 in lowering serum uric acid (sUA) in participant...

Invitation-only
Gout
Drug: ABP-671
Drug: Allopurinol

This is a multicenter, randomized, double-blind, Phase 2b/3 study to evaluate the efficacy and safety of ABP-671. Part 1 of the study will compare th...

Enrolling
Gout
Drug: ABP-671
Other: Placebo

This study is a large-scale investigation (Phase 3) into a new booster shot designed specifically for teenagers. The booster targets a particular var...

Active, not recruiting
COVID-19
Biological: Prototype/XBB.1.5 Bivalent Vaccine (5 µg)
Biological: NVX-CoV2601 co-formulated Omicron XBB.1.5 SARS-CoV-2 rS vaccine

Trial sponsors

AbbVie logo
A
American Regent logo
Exact Sciences Corporation logo
Mass General Brigham logo
Novavax logo

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems